Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators (Q33519733)

27 July 2017

title

Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators (English)

1 reference

27 July 2017

0 references

Samuel Frank

1

0 references

publication date

18 December 2009

1 reference

27 July 2017

1 reference

27 July 2017

volume

9

1 reference

27 July 2017

page(s)

62

1 reference

Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments

27 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804668

The current clinical management of Huntington's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804668

Symptomatic treatment of Huntington disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804668

Dopaminergic signaling and striatal neurodegeneration in Huntington's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804668

Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804668

Is history of depression a contraindication to treatment with tetrabenazine?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804668

Pharmacological management of Huntington's disease: an evidence-based review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804668

A rating scale for depression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804668

Reversal of tetrabenazine induced depression by selective noradrenaline (norepinephrine) reuptake inhibition

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804668

Long-term effects of tetrabenazine in hyperkinetic movement disorders

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804668

Suicide risk in Huntington's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804668

Differential interactions of phencyclidine with tetrabenazine and reserpine affecting intraneuronal dopamine.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804668

Characterization of the monoamine carrier of chromaffin granule membrane by binding of [2-3H]dihydrotetrabenazine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804668

Tetrabenazine-induced depletion of brain monoamines: Mechanism by which desmethylimipramine protects cortical norepinephrine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804668

Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804668

A rating scale for drug-induced akathisia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804668

Huntington's disease: a randomized, controlled trial using the NMDA-antagonist amantadine

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-9-62

Tetrabenazine treatment for Huntington's disease-associated chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-9-62

Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-9-62

The long-term effect of tetrabenazine in the management of Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-9-62

Short-term effects of tetrabenazine on chorea associated with Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-9-62

Unified Huntington's disease rating scale: Reliability and consistency

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-9-62

Critical periods of suicide risk in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-9-62

A study of chorea after tetrabenazine withdrawal in patients with Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-9-62

Tourettism associated with Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-9-62

A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804668

Reserpine binding to bovine chromaffin granule membranes. Characterization and comparison with dihydrotetrabenazine binding.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804668

Concentration-effect relationships of tetrabenazine and dihydrotetrabenazine in the rat

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20021666

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20021666

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Safety and tolerability of the free-radical scavenger OPC-14117 in Huntington's disease. The Huntington Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20021666

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2377-9-62

1 reference

Dimensions Publication ID

27 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2377-9-62

9 September 2019

1 reference

27 July 2017

1 reference